Quantcast
Viewing all articles
Browse latest Browse all 3999

Solid Bio's former CEO launches new rare disease startup with €65M Series A

A new startup aiming to tackle rare diseases de-stealthed Wednesday morning with a CEO experienced in the space. Alesta Therapeutics took the wraps off its €65 million Series A ($67 million) that it hopes to ...

Viewing all articles
Browse latest Browse all 3999

Trending Articles